FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

23440411000001104: EN-Potab 400mg tablets for cutaneous solution (Ennogen Healthcare Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 11-Dec 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
76888801000001117 EN-Potab 400mg tablets for cutaneous solution (Ennogen Healthcare Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
76888901000001111 EN-Potab 400mg tablets for cutaneous solution (Ennogen Healthcare Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
EN-Potab 400mg tablets for cutaneous solution (Ennogen Healthcare Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
EN-Potab 400mg tablets for cutaneous solution (Ennogen Healthcare Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
EN-Potab 400mg tablets for cutaneous solution (Ennogen Healthcare Ltd) 30 tablet Is a Potassium permanganate 400mg solution tablets 30 tablet true Inferred relationship Existential restriction modifier
EN-Potab 400mg tablets for cutaneous solution (Ennogen Healthcare Ltd) 30 tablet Has AMP EN-Potab 400mg tablets for cutaneous solution (Ennogen Healthcare Ltd) true Inferred relationship Existential restriction modifier
EN-Potab 400mg tablets for cutaneous solution (Ennogen Healthcare Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
EN-Potab 400mg tablets for cutaneous solution (Ennogen Healthcare Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
EN-Potab 400mg tablets for cutaneous solution (Ennogen Healthcare Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
EN-Potab 400mg tablets for cutaneous solution (Ennogen Healthcare Ltd) 30 tablet Has specific active ingredient Potassium permanganate true Inferred relationship Existential restriction modifier
EN-Potab 400mg tablets for cutaneous solution (Ennogen Healthcare Ltd) 30 tablet Has dispensed dose form Tablet for conventional release cutaneous solution true Inferred relationship Existential restriction modifier
EN-Potab 400mg tablets for cutaneous solution (Ennogen Healthcare Ltd) 30 tablet Legal category Legal category not applicable true Inferred relationship Existential restriction modifier
EN-Potab 400mg tablets for cutaneous solution (Ennogen Healthcare Ltd) 30 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
EN-Potab 400mg tablets for cutaneous solution (Ennogen Healthcare Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start